Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Technology | 14.17% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WSTL
4001
DELISTED
Westell Technologies Inc
WSTL
| $70K | ﹤0.01% |
22,386
-4
| -0% | -$11 |
2013 Q2
16 quarters
|
|
|
BNBX
4002
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2015 Q3
7 quarters
|
|
4003
Cardiff Oncology
CRDF
$72.3M
| $69K | ﹤0.01% |
756
-3,621
| -83% | -$233K |
2013 Q2
16 quarters
|
|
4004
DELISTED
DZS Inc. Common Stock
DZSI
| $69K | ﹤0.01% |
11,441
+296
| +3% | +$1.76K |
2013 Q2
16 quarters
|
|
|
QBAK
4005
DELISTED
Qualstar Corp
QBAK
| $68K | ﹤0.01% |
13,150
| – | – |
2016 Q3
3 quarters
|
|
4006
eGain
EGAN
$145M
| $67K | ﹤0.01% |
40,827
+2,506
| +7% | +$3.91K |
2013 Q2
16 quarters
|
|
4007
DELISTED
Golden Minerals Company
AUMN
| $66K | ﹤0.01% |
4,694
| – | – |
2013 Q2
16 quarters
|
|
4008
Full House Resorts
FLL
$39.9M
| $64K | ﹤0.01% |
26,061
| – | – |
2013 Q2
16 quarters
|
|
4009
Harrow
HROW
$1.04B
| $64K | ﹤0.01% |
20,127
| – | – |
2015 Q3
7 quarters
|
|
4010
Spyre Therapeutics
SYRE
$7.41B
| $64K | ﹤0.01% |
660
| – | – |
2017 Q1
1 quarter
|
|
|
FCSC
4011
DELISTED
Fibrocell Science Inc.
FCSC
| $64K | ﹤0.01% |
3,204
| – | – |
2013 Q2
16 quarters
|
|
|
REXX
4012
DELISTED
Rex Energy Corporation
REXX
| $64K | ﹤0.01% |
22,163
+168
| +0.8% | +$603 |
2013 Q2
16 quarters
|
|
4013
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
2015 Q4
6 quarters
|
|
4014
DELISTED
Vertex Energy, Inc
VTNR
| $63K | ﹤0.01% |
59,254
| – | – |
2014 Q2
12 quarters
|
|
|
CHMA
4015
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $63K | ﹤0.01% |
43,057
| – | – |
2015 Q3
7 quarters
|
|
|
MARK
4016
DELISTED
Remark Holdings, Inc.
MARK
| $62K | ﹤0.01% |
2,223
+28
| +1% | +$800 |
2017 Q1
1 quarter
|
|
4017
Cerenome
CNSY
$13.6M
| – | – |
0
| – | – |
2013 Q2
16 quarters
|
|
4018
Orion Energy Systems
OESX
$96.5M
| $60K | ﹤0.01% |
4,679
+125
| +3% | +$1.85K |
2013 Q2
16 quarters
|
|
|
TCON
4019
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $60K | ﹤0.01% |
125
| – | – |
2016 Q4
2 quarters
|
|
4020
DELISTED
Molecular Templates, Inc.
MTEM
| $60K | ﹤0.01% |
927
-169
| -15% | -$13.3K |
2013 Q2
16 quarters
|
|
4021
Centrus Energy
LEU
$2.36B
| $59K | ﹤0.01% |
13,867
+366
| +3% | +$1.83K |
2017 Q1
1 quarter
|
|
|
MRIN
4022
DELISTED
Marin Software
MRIN
| $58K | ﹤0.01% |
1,070
| – | – |
2013 Q2
16 quarters
|
|
|
TAT
4023
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $58K | ﹤0.01% |
48,972
| – | – |
2013 Q3
15 quarters
|
|
4024
Filana Therapeutics
FLNA
$34.7M
| $57K | ﹤0.01% |
13,836
+531
| +4% | +$2.51K |
2013 Q2
16 quarters
|
|
|
PTX
4025
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $57K | ﹤0.01% |
14,141
+2,165
| +18% | +$9.43K |
2017 Q1
1 quarter
|
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.